Zymeworks
ZYME
114 hedge funds and large institutions have $694M invested in Zymeworks in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 29 closing their positions.
65% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 26
11.52% more ownership
Funds ownership: 79.43% → 90.95% (+12%)
3% more call options, than puts
Call options by funds: $2.41M | Put options by funds: $2.33M
7% less funds holding
Funds holding: 123 → 114 (-9)
24% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 29
35% less capital invested
Capital invested by funds: $1.07B → $694M (-$376M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$55M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$47.1M |
| 3 |
Goldman Sachs
New York
|
+$46.7M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$26.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$51.3M |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$28.4M |
| 3 |
AC
Armistice Capital
New York
|
-$26.6M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$19M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.3M |
ZYME Hedge Fund Activity: Q4 2021 in Review
114 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2021, worth a combined $694M — down 35% from $1.07B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of ZYME and 22 opened new positions — a net loss of 7 holders — while 26 trimmed existing stakes and 43 added.
The largest buyer was Bank of America, adding an estimated $55M. The largest seller was Pictet Asset Management (Switzerland), exiting entirely with an estimated $51.3M sold.
- 114 institutional investors held Zymeworks (ZYME) as of Q4 2021, down from 123 in Q3 2021.
- Funds reported $694M of Zymeworks stock for Q4 2021, down 35% quarter-over-quarter.
- 22 funds opened new Zymeworks positions in Q4 2021 and 29 closed out, a net change of -7 holders.
- The largest Zymeworks buyer in Q4 2021 was Bank of America, an estimated $55M added.
- The largest Zymeworks seller in Q4 2021 was Pictet Asset Management (Switzerland), an estimated $51.3M sold.
Based on aggregated 13F filings for Q4 2021.